Hanger, Inc. has launched a unique virtual reality (VR) tool so that patients with limb loss and limb differences can have an enhanced prosthetics experience.
Hanger, Inc. Launches Virtual Reality Technology

Vinit Asar, president and CEO of Hanger, told OTW, “The initial MIGO 360-degree immersive video experience offers users an opportunity to interact with fellow amputee Cameron Clapp. Users are able to hear directly from Cameron and experience a variety of activities as if they were Cameron, from walking down stairs in his first-person point-of-view, to driving a car with two prosthetic legs and cutting food with a prosthetic arm.”
“Feedback from the initial experience will be used during the development of a full-length MIGO VR experience that will include a variety of prosthetic users of various ages and amputation levels performing a number of different activities. The extended Hanger Clinic MIGO VR experience is slated to rollout nationwide summer 2018.”
“While we see compelling and vast potential for this tool long-term, these initial experiences are designed to provide hope to those with limb loss or limb difference at any stage of their amputation or limb loss journey, showing them goals they are capable of achieving.”
“We feel this will be especially impactful for those who might be awaiting an amputation, or who have recently undergone an amputation. We want to make sure people in this situation are assured that with hard work, combined with the right clinical expertise and prosthetic technology, opportunities are limitless.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.